Professor Andrew Nicholson

Sub-specialties: Histopathology, Cytopathology, Immunochemistry (Diagnostic and Therapy-related), Respiratory Medicine.

Overview

02036532006

Overview

Professor Nicholson has co-authored over 200 publications, predominantly on interstitial lung disease and cancer He also wrote sections for the most recent WHO classification of lung tumours.

About Professor Andrew Nicholson

Alongside his work at OneWelbeck Professor Andrew Nicholson has been a Professor of Respiratory Pathology, Imperial College since 2002. He is also a Consultant Pathologist at RBHFT (1995-present) and Professor of Respiratory Pathology, Imperial College (2002-present).

He has co-authored over 200 publications, predominantly on interstitial lung disease and cancer (lung and mesothelioma), being involved in several committees internationally producing guidelines for the management of idiopathic pulmonary fibrosis and lung cancer. He also wrote sections for the most recent WHO classification of lung tumours. He has co-authored Pathology of the Lung, 2nd Edition (3rd now in press), which won first prize in the basic and clinical sciences section of the BMA book awards in 2006, and is currently co-writing the Armed Forces Institute of Pathology fascicle on lung tumours.

Personal biography

Professor Andrew Nicholson is a consultant histopathologist specialising in thoracic pathology, and an honorary professor of respiratory pathology at the National Heart and Lung Institute, Imperial College London. He has particular expertise in thoracic pathology (lung and mediastinum) and conducts research into lung cancer and interstitial lung disease in particular. He reports between 200 and 300 referrals from clinicians and other pathologists, nationally and internationally, each year.

Professor Nicholson lectures regularly at regional, national and international levels. He has spoken extensively in Europe, Asia, North and South America, and Australia, both as a guest speaker at international conferences and as a stand-alone teacher at specific lung pathology courses. He also organises a practical lung pathology course each year, which attracts attendees from around the globe.

He is the former chair of the International Association for the Study of Lung Cancer (IASLC) committee for the classification of lung tumours, as well as a member of the IASLC Staging and Prognostic Factors Committee.

Areas of Expertise

Professor Nicholson's areas of expertise include:

Histopathology
Cytopathology
Immunochemistry (diagnostic and therapy-related)

Additional Information

Memberships

British Division of International Academy of Pathologists (Secretary 2010-19, President-Elect 2018-2020).
Royal College of Pathologists (RCPath). Specialist Advisor for thoracic diseases (2010-2020) – lead author for national Data Sets for lung cancer, thymoma & mesothelioma, guidelines for UK pathologists.
International Association for the Study of Lung Cancer (IASLC): Past Chair of IASLC Pathology Committee, and member of 8th and 9th Staging and Prognostic Factors Committee.
Medical Protection Society
British Thoracic Society
European Respiratory Society
International Thymic interest Group
Fleischner Society
Cunningham Medal from British Division of International Academy of Pathologists (2018)

Awards

Mary J. Matthews Pathology/Translational Research Award from IASLC (2019).

Research Highlights

Notable Publications

Textbooks:

Corrin B and Nicholson AG. Pathology of the Lungs, 2nd Ed. Elsevier, Edinburgh. 2006 and 3rd Ed. Elsevier, Edinburgh. 2011.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer; 2015. Editor ofr 2020 Edition.
Travis WD Nicholson AG, Geisinger KR, Brambilla E. Atlas of Tumor Pathology. Series Editor S. Sternberg. Tumors of the Lower Respiratory Tract. 2019.
Andrew G Nicholson, Alain C Borzcuk, Aliya Husain. Tumors of the Serosal Membranes. Written. Due for publication in 2021.

Papers:

Nicholson AG et al. Dataset for reporting of Thymic Epithelial Tumours: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2017;70:522-538.
Husain AN et al. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142:89-108.
Raghu G et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198:e44-e68.
Yatabe Y et al. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J Thorac Oncol. 2019;14:377-407.
Nicholson AG et al.. EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol. 2020;15:29-49.
Raghu G et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;1;202:e36-e69.

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.